Enhancing the efficacy of viral vector blood-stage malaria vaccines
<p>Replication-deficient adenovirus (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This the...
Hlavní autor: | Forbes, E |
---|---|
Další autoři: | Hill, A |
Médium: | Diplomová práce |
Jazyk: | English |
Vydáno: |
2011
|
Témata: |
Podobné jednotky
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
Autor: Kapulu, MC
Vydáno: (2014) -
Developing novel blood-stage malaria vaccines
Autor: Douglas, AD
Vydáno: (2015) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
Autor: Bauza, K
Vydáno: (2012) -
Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
Autor: de Cassan, S
Vydáno: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
Autor: Elias, SC
Vydáno: (2014)